A new photosynthesis system never before seen in nature that can improve the use of one-carbon substrates in Escherichia coli ...

The company said it will stop the Phase III trial of ExPEC after interim results found it failed to demonstrate efficacy over ...

A comprehensive seven-year study across 20 Chinese provinces has revealed a concerning rise in antimicrobial resistance (AMR) ...

An E coli infection linked to the death of a doctor in Princess Margaret Hospital is unlikely to lead to widespread ...

Johnson & Johnson and Sanofi's vaccine for preventing invasive disease caused by the problem pathogen Escherichia coli looks all but defunct after the two partners halted a phase 3 trial.

Escherichia coli, commonly known as E. coli, is a versatile bacterium. While many strains are harmless and a natural part of our intestinal ...

The skin serves as the body's primary defense against harmful microorganisms, toxins, and physical damage. However, severe ...

A new study published in Biochemistry sheds light on how bacteria regulate their genes, challenging long-held assumptions ...

By analyzing E. coli protein levels, scientists found a surplus of membrane shuttle proteins that may play a role in antibiotic resistance.

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

Maharashtra's Health Department reports a rise in Guillain-Barre Syndrome cases, diagnosing 140 individuals. The Pune ...

The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.